Operose Advisors’s Neogen NEOG Stock Holding History

Operose Advisors’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-545	Closed	-$10.1K	–	687
2023 Q3	$10.1K	Buy	+545	New	+$11.9K	﹤0.01%	578

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Operose Advisors's NEOG Position: Q4 2023 in Review

Operose Advisors sold out of Neogen (NEOG) in Q4 2023, closing a stake of 545 shares — an estimated $10.1K sold.

Operose Advisors first reported a position in NEOG in Q3 2023 and held it in 1 quarter. The position peaked at $10.1K in Q3 2023. 340 funds tracked by Wall St. Rank hold NEOG as of Q4 2023.

Operose Advisors reported no remaining Neogen position as of Q4 2023 after selling out during the quarter.
Operose Advisors sold 545 Neogen shares in Q4 2023, an estimated $10.1K.
Operose Advisors first reported a position in Neogen in Q3 2023 and held it in 1 quarter.
Operose Advisors's Neogen position peaked at $10.1K in Q3 2023.
340 funds tracked by Wall St. Rank held Neogen as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.